Translational Drug Development (TD2)

Scottsdale,  AZ 
United States
  • Booth: 504

Guiding neuro-oncology therapies from early detection of response to approval. Partner with a small, flexible CRO who cares about your research as much as you do.

TD2 provides innovative services for improved and accelerated development of therapies for glioblastoma and neuro-oncology. Our team has deep experience and understanding of GBM PDX models for preclinical development. This combined with regulatory strategy expertise, guides customized clinical trial design and execution. Our capabilities encourage the timely selection of patient populations who are most likely to benefit from a new agent and the rapid identification of clinically significant endpoints. 

Brands: Glioblastoma PDX Models Regulatory Strategy & Support Comprehensive Clinical Trial Management

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".